We are live on ! Find out more
CD

Christopher Davis Davis Selected Advisers

AUM $23.3B
1-Year Est. Return 26.95%
 

Christopher Davis is chairman of Davis Advisors, a multi-generational investment firm known for research-intensive equity management. The firm’s strategies often emphasize financials and other businesses where long-term ownership and careful accounting analysis matter. Davis is a frequent public commentator on active management and long-horizon investing.

This Fund
S&P 500
This Quarter Est. Return
+3.91%
1 Year Est. Return
+26.95%
3 Year Est. Return
+93.11%
5 Year Est. Return
+96.73%
10 Year Est. Return
+388.76%
AUM
$22.9B
AUM Growth
-$331M
Cap. Flow
-$1.06B
Cap. Flow %
-4.63%
Top 10 Hldgs %
47.88%
Holding
146
New
5
Increased
59
Reduced
74
Closed
4

Top Sells

Rank Stock Value
1
MON
Monsanto Co
MON
+$550M
2
AMZN icon
Amazon
AMZN
+$169M
3
JPM icon
JPMorgan Chase
JPM
+$152M
4
V icon
Visa
V
+$95.4M
5
UNH icon
UnitedHealth
UNH
+$66.7M

Sector Composition

Rank Sector Weight
1 Financials 38.79%
2 Consumer Discretionary 13.4%
3 Communication Services 12.27%
4 Energy 10.41%
5 Industrials 9.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
Y
51
DELISTED
Alleghany Corp
Y
$46.4M 0.2%
+77,974
New +$46.4M
STT icon
52
State Street
STT
$51.4B
$44.3M 0.19%
493,517
+8,106
+2% +$674K
KKR icon
53
KKR & Co
KKR
$97.4B
$43.1M 0.19%
2,317,264
+24,659
+1% +$451K
ETN icon
54
Eaton
ETN
$163B
$41.5M 0.18%
533,228
+21,036
+4% +$1.6M
NOAH
55
Noah Holdings
NOAH
$604M
$41.1M 0.18%
1,434,298
+168,882
+13% +$4.48M
MRSH
56
Marsh
MRSH
$91.6B
$40.1M 0.18%
513,972
+7,158
+1% +$541K
VIPS icon
57
Vipshop
VIPS
$6.98B
$39.2M 0.17%
3,719,303
+183,097
+5% +$2.39M
PNC icon
58
PNC Financial Services
PNC
$97B
$38.4M 0.17%
307,362
+5,262
+2% +$635K
SPG icon
59
Simon Property Group
SPG
$70.6B
$35.3M 0.15%
218,446
-81
-0% -$13.2K
SCHW
60
Charles Schwab
SCHW
$194B
$35.2M 0.15%
819,312
+6,087
+0.7% +$244K
DFNL icon
61
Davis Select Financial ETF
DFNL
$483M
$32.5M 0.14%
1,505,850
+496,400
+49% +$10.4M
LILAK icon
62
Liberty Latin America Class C
LILAK
$1.64B
$30.8M 0.13%
1,679,342
-163,033
-9% -$2.99M
AMAT icon
63
Applied Materials
AMAT
$391B
$30.6M 0.13%
741,934
-41,678
-5% -$1.77M
NVS icon
64
Novartis
NVS
$302B
$29.4M 0.13%
393,747
+60,387
+18% +$4.28M
LVNTA
65
DELISTED
Liberty Interactive Corporation Series A Liberty Ventures
LVNTA
$28.9M 0.13%
553,245
-60,110
-10% -$3.14M
TV icon
66
Televisa
TV
$1.47B
$28.5M 0.12%
1,169,011
+38,956
+3% +$968K
DUSA icon
67
Davis Select US Equity ETF
DUSA
$1.27B
$28.2M 0.12%
1,340,700
+334,800
+33% +$6.91M
BN icon
68
Brookfield
BN
$93.1B
$27.8M 0.12%
1,990,246
-14,339
-0.7% -$193K
DWLD icon
69
Davis Select Worldwide ETF
DWLD
$611M
$27.3M 0.12%
1,228,000
+284,300
+30% +$6.24M
SPGI icon
70
S&P Global
SPGI
$127B
$26.5M 0.12%
181,288
+4,810
+3% +$668K
DPLO
71
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
$25.2M 0.11%
1,703,992
+71,846
+4% +$1.2M
CTT
72
DELISTED
CATCHMARK TIMBER TRUST, INC.
CTT
$25.2M 0.11%
2,214,587
-126,770
-5% -$1.47M
MCO icon
73
Moody's
MCO
$87.2B
$24.5M 0.11%
201,306
-164
-0.1% -$19.2K
AIG icon
74
American International
AIG
$39.8B
$22.1M 0.1%
354,294
-2,466
-0.7% -$153K
AVB
75
DELISTED
AvalonBay Communities
AVB
$22M 0.1%
114,501
-174
-0.2% -$33.3K

Similar funds

Christopher Davis's Q2 2017 Portfolio in Review

As of Q2 2017, Christopher Davis held 146 positions worth $22.9B, down 1.4% from $23.2B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Christopher Davis withdrew a net $1.06B in Q2 2017, closing 4 positions and reducing 74 holdings. Its most notable exit was Bausch Health, an estimated $43.2M position sold in full.

By sector, the portfolio is most concentrated in Financials at 39% of assets, up from 37% a quarter earlier, followed by Consumer Discretionary and Communication Services.

Against the trend, Christopher Davis opened a new position in Alleghany Corp worth $46.4M.

  • Christopher Davis's largest Q2 2017 buy was Alleghany Corp: 77,974 shares worth $46.4M.
  • Christopher Davis added most to Capital One in Q2 2017, an estimated $347M increase.
  • Christopher Davis's biggest Q2 2017 reduction was Monsanto Co, cutting an estimated $550M.
  • Christopher Davis fully exited Bausch Health in Q2 2017, selling an estimated $43.2M.
  • Christopher Davis's ten largest holdings make up 48% of its $22.9B portfolio in Q2 2017.
  • Christopher Davis opened 5 new positions and closed 4 in Q2 2017.
  • Christopher Davis's portfolio value fell 1.4% quarter-over-quarter to $22.9B.

Based on Davis Selected Advisers's 13F filing for Q2 2017, filed 9 Aug 2017.